本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ocular Therapeutix

10.49
-0.1300-1.22%
盤後10.690.2000+1.91%19:56 EDT
成交量:263.02萬
成交額:2,774.89萬
市值:22.96億
市盈率:-7.42
高:10.94
開:10.75
低:10.37
收:10.62
52周最高:16.44
52周最低:6.23
股本:2.19億
流通股本:1.85億
量比:1.16
換手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
淨資產收益率:-72.99%
總資產收益率:-34.95%
市淨率:4.42
市盈率(LYR):-7.39

資料載入中...

2024/07/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/18

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

重要事件披露

Form 8-K - Current report